BAGNEUX, France, April 15, 2014 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new reference in the treatment of allergy, announced today its topline financial results, as well as its net cash position, for first three months 2014.
Help employers find you! Check out all the jobs and post your resume.
